Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19110637rdf:typepubmed:Citationlld:pubmed
pubmed-article:19110637lifeskim:mentionsumls-concept:C0026339lld:lifeskim
pubmed-article:19110637lifeskim:mentionsumls-concept:C0012984lld:lifeskim
pubmed-article:19110637lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:19110637lifeskim:mentionsumls-concept:C0018951lld:lifeskim
pubmed-article:19110637lifeskim:mentionsumls-concept:C1517476lld:lifeskim
pubmed-article:19110637pubmed:dateCreated2008-12-26lld:pubmed
pubmed-article:19110637pubmed:abstractTextLarge animal models have played a crucial role in the development of gene therapy protocols. A significant advantage of large animal models over rodent models includes the ability to more easily translate protocols developed in large animals to humans. For gene therapy applications, nonhuman primates and canines have been the main large animal models. Canines have the advantage that there are disease models available, e.g., hemolytic anemia (pyruvate kinase deficiency), leukocyte adhesion deficiency, severe combined immunodeficiency (XSCID), storage diseases, and others. In addition, all three major integrating virus systems, i.e., gammaretrovirus-, HIV-derived lenti- and foamy virus vectors are able to efficiently transduce canine hematopoietic cells. Here we describe protocols developed for efficient transduction of canine hematopoietic repopulating cells.lld:pubmed
pubmed-article:19110637pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19110637pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19110637pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19110637pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19110637pubmed:languageenglld:pubmed
pubmed-article:19110637pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19110637pubmed:citationSubsetIMlld:pubmed
pubmed-article:19110637pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19110637pubmed:statusMEDLINElld:pubmed
pubmed-article:19110637pubmed:issn1064-3745lld:pubmed
pubmed-article:19110637pubmed:authorpubmed-author:KiemHans-Pete...lld:pubmed
pubmed-article:19110637pubmed:authorpubmed-author:BeardBrian...lld:pubmed
pubmed-article:19110637pubmed:issnTypePrintlld:pubmed
pubmed-article:19110637pubmed:volume506lld:pubmed
pubmed-article:19110637pubmed:ownerNLMlld:pubmed
pubmed-article:19110637pubmed:authorsCompleteYlld:pubmed
pubmed-article:19110637pubmed:pagination341-61lld:pubmed
pubmed-article:19110637pubmed:meshHeadingpubmed-meshheading:19110637...lld:pubmed
pubmed-article:19110637pubmed:meshHeadingpubmed-meshheading:19110637...lld:pubmed
pubmed-article:19110637pubmed:meshHeadingpubmed-meshheading:19110637...lld:pubmed
pubmed-article:19110637pubmed:meshHeadingpubmed-meshheading:19110637...lld:pubmed
pubmed-article:19110637pubmed:meshHeadingpubmed-meshheading:19110637...lld:pubmed
pubmed-article:19110637pubmed:meshHeadingpubmed-meshheading:19110637...lld:pubmed
pubmed-article:19110637pubmed:meshHeadingpubmed-meshheading:19110637...lld:pubmed
pubmed-article:19110637pubmed:meshHeadingpubmed-meshheading:19110637...lld:pubmed
pubmed-article:19110637pubmed:meshHeadingpubmed-meshheading:19110637...lld:pubmed
pubmed-article:19110637pubmed:meshHeadingpubmed-meshheading:19110637...lld:pubmed
pubmed-article:19110637pubmed:meshHeadingpubmed-meshheading:19110637...lld:pubmed
pubmed-article:19110637pubmed:meshHeadingpubmed-meshheading:19110637...lld:pubmed
pubmed-article:19110637pubmed:year2009lld:pubmed
pubmed-article:19110637pubmed:articleTitleCanine models of gene-modified hematopoiesis.lld:pubmed
pubmed-article:19110637pubmed:affiliationFred Hutchinson Cancer Research Center, Seattle, WA, USA.lld:pubmed
pubmed-article:19110637pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19110637pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19110637lld:pubmed